University of California San Francisco
Give to UCSF
NSF Funds ‘Blue Sky’ Bioengineering Center To Be Based at UCSF
The National Science Foundation has awarded $24 million over five years for a new ‘blue-sky’ bioengineering center based at UCSF.
Howard Hughes Medical Institute Names 4 UCSF Researchers as Faculty Scholars
Four UCSF researchers are among the 84 Faculty Scholars named by the Howard Hughes Medical Institute, the Simons Foundation, and the Bill & Melinda Gates Foundation in a new program to support promising early-career scientists.
Joe DeRisi on How the Biohub Will Create Opportunities for Research Collaboration
Joe DeRisi, co-director of the new Chan Zuckerberg Biohub at Mission Bay, speaks about his vision for the Biohub and what researchers can look forward to.
3 Leading Bay Area Research Universities to Partner in $600M Chan Zuckerberg Medical Science 'Biohub'
UCSF, Stanford and UC Berkeley will join forces in a new biomedical science research center funded by a $600 million commitment from Facebook CEO and founder Mark Zuckerberg and pediatrician Priscilla Chan.
Bruce Alberts on Why Biomedical Research Needs Rescuing
Bruce Alberts and a group of prominent scientists have begun the Rescuing Biomedical Research initiative to fix what they see as systemic flaws in the current biomedical research enterprise.
UCSF's Bruce Alberts Wins Lasker-Koshland Award for Lifetime of Research, Science Advocacy
UCSF biochemist Bruce Alberts has received the 2016 Lasker~Koshland Special Achievement Award in Medical Science, one of the highest honors in biomedicine.
Go-Between Immune Cell is Key to Priming the Body’s Fight Against Cancer
Using advanced imaging technology that allowed them to spy on interactions among cells in the lymph nodes of living mice, a research team led by UCSF scientists has identified a cell that is a key player in mounting the immune system’s defense against cancer.
Covert Inflammation May Trigger Many Forms of Cancer
A previously unidentifiable type of low-grade inflammation may explain why common anti-inflammatory drugs such as aspirin have shown promise against some types of cancer – even when patients don’t display typical signs of inflammation.
Tarantula Toxins Offer Key Insights Into Neuroscience of Pain
Researchers have identified a pair of tarantula toxins that target a previously unknown pain pathway in sensory nerves.
Hybrid Cancer Drug Could Be Resistance-Resistant
A team of cancer researchers led by scientists at UCSF and Memorial Sloan Kettering Cancer Center in New York have developed a first-of-its-kind hybrid drug with the power to outsmart drug-resistant cancers.
David Morgan Delivers 59th Annual Faculty Research Lecture in Basic Science
David O. Morgan, PhD, has been selected as the recipient of the 59th Annual Faculty Research Lectureship – Basic Science for his groundbreaking research on cell division.